DrugPatentWatch Database Preview
Patent: 8,974,802
» See Plans and Pricing
Summary for Patent: 8,974,802
| Title: | Medicament for the treatment of cancer of the pancreas |
| Abstract: | The invention relates to a suspension of red corpuscles encapsulating asparaginase as a medicament for treating pancreatic cancer. It in particular concerns a therapeutic composition or medicament intended for the treatment of pancreatic cancer, containing an effective quantity of such a suspension of red corpuscles. |
| Inventor(s): | Dufour; Emmanuelle-Cecile (Lyons, FR), Godfrin; Yann (Lyons, FR) |
| Assignee: | Erytech Pharma (Lyons, FR) |
| Application Number: | 12/810,164 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,974,802
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Erytech Pharma (Lyons, FR) | 2027-12-24 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,974,802
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2009080837 | Start Trial |
| United States of America | 2010310612 | Start Trial |
| Slovenia | 2224950 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
